rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David Tsur

Director

Company insider

Files Form 4 as: Director, Kamada.

Every Form 4 they filed

In numbers

Trades disclosed
58
Buys
0
Sells
4
Bought
$0
Sold
$3.3M
Companies
1
Companies where not an officer
1
First trade
7 Apr 2026
Last trade
14 Sep 2026
Last filed
23 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
KMDA KamadaDirector · Biotechnology · last 14 Sep 20260 buys · 4 sells

Activity over time

1 Sep – 1 Oct
401 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Sep 2026filed 17 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$187K22,827 at $8.18filing
14 Sep 2026filed 17 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$187K22,827 at $8.18filing
9 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$1,446175 at $8.26filing
9 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$1,446175 at $8.26filing
8 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$1.3M162,760 at $8.26filing
8 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$1.3M162,760 at $8.26filing
7 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$118K14,238 at $8.28filing
7 Sep 2026filed 11 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Sold$118K14,238 at $8.28filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code M$195K26,500 at $7.36filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code F$23K2,760 at $8.30filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code M$134K22,500 at $5.94filing
2 Sep 2026filed 8 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code M—26,500 at $0.00filing
2 Sep 2026filed 8 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code M—22,500 at $0.00filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code F$53K6,406 at $8.26filing
2 Sep 2026filed 8 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code M—26,500 at $0.00filing
2 Sep 2026filed 8 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code M—22,500 at $0.00filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code M$195K26,500 at $7.36filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code F$23K2,760 at $8.30filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code M$134K22,500 at $5.94filing
2 Sep 2026filed 8 Sep 2026KMDA KamadaBiotechnologySEC FORM 4 Code F$53K6,406 at $8.26filing

News

Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026KMDA · manilatimes.net · 19 Oct 2026

0 headlines in the last 90 days name David Tsur; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Ishay DavidiDirector and 10% owner · Director and 10% owner at Kamada, filing Form 4 there in the last year
Uri BotzerDirector · Director at Kamada, filing Form 4 there in the last year
Lilach Asher-TopilskyDirector · Director at Kamada, filing Form 4 there in the last year
Amir LondonChief Executive Officer · Chief Executive Officer at Kamada, filing Form 4 there in the last year
Shavit BeladevVP Plasma Operations · VP Plasma Operations at Kamada, filing Form 4 there in the last year